Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bergman

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Plos Biology|June 9, 2020
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coliCaroline Boulouis, Wan Rong Sia, Muhammad Yaaseen Gulam, et al.
Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Cell Host & Microbe|January 11, 2024
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variantThomas R Müller, Yu Gao, Jinghua Wu, et al.
Clinical & Translational Immunology|February 13, 2026
The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipientsFredrika Hellgren, Rodrigo Arcoverde Cerveira, Gustaf Lindgren, et al.
Science Translational Medicine|July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised statesThomas R Müller, Takuya Sekine, Darya Trubach, et al.
BMJ (Clinical Research Ed.)|February 17, 2017
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant dataAdrian R Martineau, David A Jolliffe, Richard L Hooper, et al.
Journal of Clinical Immunology|November 15, 2025
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter StudyCaroline Stenlander, Hannes Lindahl, Emelie Wahren-Borgström, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Plos Biology|June 9, 2020
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coliCaroline Boulouis, Wan Rong Sia, Muhammad Yaaseen Gulam, et al.
Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Cell Host & Microbe|January 11, 2024
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variantThomas R Müller, Yu Gao, Jinghua Wu, et al.
Clinical & Translational Immunology|February 13, 2026
The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipientsFredrika Hellgren, Rodrigo Arcoverde Cerveira, Gustaf Lindgren, et al.
Science Translational Medicine|July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised statesThomas R Müller, Takuya Sekine, Darya Trubach, et al.
BMJ (Clinical Research Ed.)|February 17, 2017
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant dataAdrian R Martineau, David A Jolliffe, Richard L Hooper, et al.
Journal of Clinical Immunology|November 15, 2025
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter StudyCaroline Stenlander, Hannes Lindahl, Emelie Wahren-Borgström, et al.
Pageof 18